French drugmaker Sanofi has made a $40 million investment in Gyroscope Therapeutics, with another $20 million potentially on offer as the UK biotech advances its clinical-stage gene therapies for ...
Gyroscope Therapeutics and its gene therapy for the sight-robbing disease geographic atrophy (GA) has been acquired by a big pharma company – but likely not the one you would expect. Just a few weeks ...
Abstract: The miniaturization and integration of optical gyroscopes have urgent application demands in the field of inertial sensors. The key to achieving the miniaturization and integration of an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results